12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Monday's after-market session. ASLAN Pharma, Biora Therapeutics, Qualigen Therapeutics, CVRx, China Pharma Holdings, and Fresh2 Group saw gains, while Anitra, Mustang Bio, ENDRA Life Sciences, Nexalin Technology, PAVmed, and Tiziana Life Sciences experienced losses.
June 17, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Anitra shares decreased by 21.3% to $0.18, with a market cap of $5.3 million.
AZTR's significant price drop indicates negative investor sentiment, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Mustang Bio shares fell 15.98% to $0.63, with a market cap of $17.7 million.
MBIO's significant price drop suggests negative market reaction, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
ENDRA Life Sciences shares declined by 14.39% to $0.12, with a market cap of $2.0 million.
NDRA's significant price drop indicates negative investor sentiment, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Nexalin Technology shares fell 9.2% to $0.69, with a market cap of $5.0 million.
NXL's price drop suggests negative market reaction, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
PAVmed stock fell 8.92% to $0.92, with a market cap of $8.6 million.
PAVM's price drop indicates negative investor sentiment, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Tiziana Life Sciences shares fell 8.8% to $0.72, with a market cap of $73.1 million.
TLSA's price drop suggests negative market reaction, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
ASLAN Pharma shares rose by 11.9% to $0.4, with a market cap of $9.1 million.
ASLN's significant price increase indicates positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Biora Therapeutics shares rose 11.64% to $0.75, with a market cap of $26.9 million.
BIOR's significant price increase suggests strong investor interest, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
China Pharma Holdings stock increased by 8.68% to $0.27.
CPHI's price increase indicates positive market sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
CVRx stock moved upwards by 9.48% to $12.0, with a market cap of $259.1 million.
CVRX's price increase suggests strong investor confidence, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Fresh2 Group shares rose 7.56% to $0.34, with a market cap of $8.3 million.
FRES's price increase suggests positive investor sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Qualigen Therapeutics shares increased by 10.99% to $0.19, with a market cap of $1.2 million.
QLGN's price increase indicates positive market reaction, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 100